These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 16756632

  • 1. Kidney-specific gene targeting: insight into thiazolidinedione-induced fluid retention.
    Yang T.
    Nephrology (Carlton); 2006 Jun; 11(3):201-6. PubMed ID: 16756632
    [Abstract] [Full Text] [Related]

  • 2. Fluid retention mediated by renal PPARgamma.
    Staels B.
    Cell Metab; 2005 Aug; 2(2):77-8. PubMed ID: 16098822
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
    Burton JD, Castillo ME, Goldenberg DM, Blumenthal RD.
    Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS, Warburton P, O'Regan DJ, Ball SG, Turner NA, Porter KE.
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D, Qi H, Gabriele S, Catalano S, Aquila S, Belmonte M, Andò S.
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [Abstract] [Full Text] [Related]

  • 13. Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer.
    Inamoto T, Shah JB, Kamat AM.
    Urol Oncol; 2009 Jun; 27(6):585-91. PubMed ID: 19162510
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA, Cruciani-Guglielmacci C, Kassis N, Clément L, Ouali F, Caüzac M, Lebègue N, Berthelot P, Caignard DH, Pégorier JP, Renard P, Dacquet C, Ktorza A, Magnan C, Consortium of the French Ministry of Research and Technology.
    Eur J Pharmacol; 2009 Apr 17; 608(1-3):104-11. PubMed ID: 19250932
    [Abstract] [Full Text] [Related]

  • 17. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
    Tönjes A, Stumvoll M.
    Curr Opin Clin Nutr Metab Care; 2007 Jul 17; 10(4):410-4. PubMed ID: 17563457
    [Abstract] [Full Text] [Related]

  • 18. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.
    Gavériaux-Ruff C, Kieffer BL.
    Pharmacol Ther; 2007 Mar 17; 113(3):619-34. PubMed ID: 17289150
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
    Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GE, Gustafson TA.
    Diabetes; 2006 Sep 17; 55(9):2523-33. PubMed ID: 16936200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.